Filing Details
- Accession Number:
- 0001192482-19-000447
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-26 19:18:55
- Reporting Period:
- 2019-11-22
- Accepted Time:
- 2019-11-26 19:18:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1372299 | Ocugen Inc. | OCGN | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1790205 | Junge Zhang | C/O Ocugen, Inc. 5 Great Valley Parkway Suite 160 Malvern PA 19355 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-11-22 | 80,000 | $0.28 | 215,078 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-11-25 | 115,000 | $0.27 | 330,078 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 212,863 | Indirect | By Gupiao Trust |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions ranging from $0.27 to $0.28. The reporting person undertakes to provide Ocugen, Inc., any security holder of Ocugen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in footnote (1) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions ranging from $0.26 to $0.27. The reporting person undertakes to provide Ocugen, Inc., any security holder of Ocugen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in footnote (2) to this Form 4.